Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Todorova, L. Bjermer, A. Miller-Larsson, G. Westergren-Thorsson (Lund, Sweden). Inhibitory effects of budesonide/formoterol on extracellular matrix in TGFß1-stimulated bronchial biopsy fibroblasts from mild asthmatic patients. Eur Respir J 2008; 32: Suppl. 52, 3623

Member's Comments

No comment yet.

Related content which might interest you: Inhibitory effects of budesonide and formoterol in combination on TGFβ-induced proteoglycan production by bronchial biopsy fibroblasts from healthy and mild asthmatic subjects Source: Eur Respir J 2007; 30: Suppl. 51, 352s Year: 2007 Procollagen I synthesis induced by TGFβ1 in bronchial biopsy fibroblasts from mild asthma patients is decreased by the budesonide/formoterol combination treatment Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009 Effect of inhaled budesonide on BAL inflammatory cells and MMP-12 expression in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 611s Year: 2007 Effect of oral and inhalation corticosteroids on osseous tissue condition for patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 51s Year: 2002 Anti-inflammatory effect of budesonide on the central and peripheral airway inflammation in cough-variant and mild bronchial asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Absence of sputum eosinophils in subjects with symptomatic asthma on inhaled budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002 Transbronchial fibroblasts from mild asthmatics have different proteoglycan production and migratory properties compared to transbronchial fibroblasts from rhinitis patients Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma Year: 2007 Effect of salmeterol in asthmatic patients with low sputum eosinophils Source: Eur Respir J 2001; 18: Suppl. 33, 336s Year: 2001 Effects of formoterol-budesonide combination on residual eosinophilic inflammation in distal airway of patients with well-controlled moderate asthma Source: Annual Congress 2011 - Asthma management and response Year: 2011 Influence of endogenous corticosteroids on bronchial protective properties of β2-agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 Effects of fluticasone and ciclesonide on pulmonary function and airway inflammation in stable mild asthmatics Source: Annual Congress 2009 - Aspects of clinical asthma Year: 2009 Protective effects of tiotropium bromide on the morphological remodeling of the bronchi on the neocollagenesis processes in patients with moderate COPD during exacerbation Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Protective effect of salbutamol on peripheral airway constriction induced by sputum induction in asthma patients Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Bronchial fibrocyte accumulation in COPD patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Effect of the addition of montelukast on airway inflammation and remodeling in symptomatic asthma Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 Small airway fibroblasts from COPD patients are senescent and pro-fibrotic Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases Year: 2018 Effect of the addition of montelukast to inhaled fluticasone propionate on immunopathology in bronchial biopsies from mild to moderate asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 388s Year: 2002 CCSP modulates inflammation in bronchial epithelium differentiated ex vivo from bronchial biopsy of COPD patients Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 Espression of clusterin and CD44 in bronchial biopsies of subjects with asthma and COPD Source: Eur Respir J 2004; 24: Suppl. 48, 321s Year: 2004